Pub. Date : 2015 May
PMID : 25802231
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Ibrutinib (Imbruvica ) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton"s tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK. | ibrutinib | Bruton tyrosine kinase | Homo sapiens |
| 2 | Ibrutinib (Imbruvica ) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton"s tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK. | ibrutinib | Bruton tyrosine kinase | Homo sapiens |
| 3 | Ibrutinib (Imbruvica ) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton"s tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK. | ibrutinib | Bruton tyrosine kinase | Homo sapiens |
| 4 | Ibrutinib (Imbruvica ) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton"s tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK. | ibrutinib | Bruton tyrosine kinase | Homo sapiens |
| 5 | Ibrutinib (Imbruvica ) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton"s tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK. | ibrutinib | Bruton tyrosine kinase | Homo sapiens |
| 6 | Ibrutinib (Imbruvica ) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton"s tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK. | ibrutinib | Bruton tyrosine kinase | Homo sapiens |